Question

A 58-year-old with diabetes and ASCVD has A1C 8.2% on metformin. He asks about cardiovascular risk reduction. Which addition aligns with guidelines?

Accepted Answer

Add an SGLT2 inhibitor or GLP-1 receptor agonist with proven cardiovascular benefit

Answer

Increase metformin to 3000 mg/day

Answer

Add sulfonylurea as first add-on

Answer

Start basal insulin immediately

Answer

Stop metformin and use TZD monotherapy

Practice question

A 58-year-old with diabetes and ASCVD has A1C 8.2% on metformin. He asks about cardiovascular risk reduction. Which addition aligns with guidelines?